Periodontal diseases may alter some systemic diseases and general health by changing the host response. In addition, some systemic diseases affect periodontal health. This study purposed to assess the periodontal status of individuals with rheumatoid arthritis (RA) receiving different drug treatments. A total of 160 individuals, 80 with RA and 80 systemically healthy individuals, were retrospectively included in the study. Individuals with RA were classified into two groups based on the medications they used, conventional synthetic disease-modifying anti-rheumatic drugs (csDMARDs)+glucocorticoids (n=40) and csDMARDs+TNF-α inhibitor (n=40). The participants’ plaque index (PI), gingival index (GI), bleeding on probing (BOP), probing depth (PD), and clinical attachment loss (CAL) values were noted. In addition, duration of disease, type of medication, duration of medication use, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), Disease Activity Score (DAS) 28-ESR, DAS 28-CRP, tender joint count (TJC), swollen joint count (SJC), rheumatoid factor, and visual analog scale (VAS) values were recorded. Appropriate statistical tests were performed. Compared with individuals with RA, BOP, GI, PI, and PD values were higher in the systemically healthy individuals (p
Key words: Disease modifying anti-rheumatic drug, periodontal disease, rheumatoid arthritis, tumor necrosis factor-alpha inhibitor
|
